The Norwegian Biotechnology Advisory Board

The Norwegian Biotechnology Advisory Board is an independent body consisting of 21 members appointed by the Norwegian government. Each member has a background and/or education which makes him/her competent to discuss questions regarding modern biotechnology. Eight members of the board represent different public organisations. The main tasks of the Norwegian Biotechnology Advisory Board is to evaluate the social and ethical consequences of modern biotechnology and to discuss usage which promotes sustainable development.

The Norwegian Biotechnology Advisory Board has approximately ten regular board meetings and organises two to three public conferences annually.

The secretariat of the Norwegian Biotechnology Advisory Board has five employees assisting and coordinating the board.

The Norwegian Biotechnology Advisory Board publishes the free, quarterly journal "Genialt" in Norwegian. In addition it makes information pamphlets on various topics regarding modern biotechnology.

Discussion papers:

"Gene medication or genetic modification? The devil is in the details", Foss, G.S & Rogne S.

Sustainability, benefit to the community and ethics in the assessment of genetically modified organisms

Regulation of DNA vaccines and gene therapy on animals

For further information, please contact the secretariat of the Norwegian Biotechnology Advisory Board at the phone number or address to the left.